feed,title,long_url,short_url
Benzinga,FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder,https://benzinga.com/general/biotech/23/08/33959971/fda-approves-regenerons-drug-for-ultra-rare-immune-disorder,https://da.gd/ijF5E
